Want to see IMBBY full AI Analyst Report?
Imperial Brands (IMBBY) AI Stock Analysis
Imperial Brands
(Other OTC:IMBBY)
The overall score of 66 reflects a financially resilient but leveraged tobacco business with dependable cash generation and stable guidance, combined with an attractive low-P/E, high-yield valuation, offset by a clearly negative price trend, recent margin and free-cash-flow volatility, and only modest near-term profit growth despite ongoing strategic and efficiency progress.
Imperial Brands Key Performance Indicators (KPIs)
Tobacco VolumeMeasures the total quantity of tobacco products sold, indicating consumer demand and market share in the tobacco industry.
Imperial Brands (IMBBY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $29.67B
- Dividend Yield
- 5.49%
- Average Volume (3M)
- 193.59K
- Price to Earnings (P/E)
- 13.8
- Beta (1Y)
- -0.29
- Revenue Growth
- 10.00%
- EPS Growth
- -25.42%
- Country
- US
- Employees
- 25,100
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Tobacco
Imperial Brands Business Overview & Revenue Model
Company Description
Imperial Brands PLC, along with its various subsidiaries, operates globally, primarily focusing on the manufacturing, sourcing, marketing, and sale of tobacco and related products across continents including Europe, the Americas, Africa, Asia, and Au...
How the Company Makes Money
Imperial Brands makes money primarily by selling tobacco and nicotine products to wholesalers, distributors, and retailers (and, in some markets, directly to retail accounts). Its main revenue stream comes from combustible tobacco: (1) cigarettes, wh...
Imperial Brands Earnings Call Summary
The call presented a broadly constructive operational and financial picture: strong cash generation (GBP 2.6bn), sustained capital returns (dividend increase and GBP 1.45bn buyback), confirmed full-year guidance, and clear progress on NGP scale, vapor/heated tobacco momentum and a GBP 320m efficiency program. These positives were partially offset by H1 one-offs (>GBP 50m), modest adjusted operating profit growth (+0.6%), a sharp Australia volume decline (~50%), and short-term promotional drag in U.S. NGP (~GBP 13m). Management expects many headwinds to ease in H2 and reiterated guidance, indicating confidence in a step-up in performance.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management reconfirmed full‑year guidance and a wide range of key metrics: tobacco net revenue growth expected in the low single digits and NGP net revenue growth in the double digits, adjusted operating profit growth targeted within the mid‑term 3–5% range, and at least high‑single‑digit EPS growth; free cash flow guidance is at least GBP 2.2bn (including 2030 implementation and Delaware cash costs). First‑half and 12‑month traction included group adjusted operating profit +0.6% (H1), 12‑month free cash flow GBP 2.6bn, operating cash conversion 98% (12‑month), leverage 2.4x (flat YoY) and expected to be around the lower end of the target range at year‑end, and an adjusted effective tax rate of 23.5% (flat). H1 saw price/mix strength (Europe +6%, U.S. +5.7%, AAACE ex‑Australia +6.1%), over GBP 50m of identified one‑offs in H1 (including ~GBP 13m NGP promotional impact), a GBP 150m Delaware cash payment in H1 (GBP 162m remaining in roughly equal instalments over three years), a 4% increase in the ordinary dividend, and an on‑track GBP 1.45bn share buyback (part of GBP 4.8bn total buybacks and GBP 11.5bn cumulative capital returns since FY21); foreign‑exchange is expected to be a 0–1% headwind to operating profit and EPS.
Imperial Brands Financial Statement Overview
Summary
Solid, recurring revenues and healthy operating profitability are supported by strong cash conversion, but high leverage, shrinking equity, margin pressure, and volatile free cash flow keep the financial profile only moderately above average.
Income Statement
68PositiveBalance Sheet
54NeutralCash Flow
60Neutral| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.54B | 32.17B | 32.41B | 32.48B | 32.55B | 32.79B |
| Gross Profit | 6.73B | 7.00B | 6.78B | 6.68B | 6.04B | 6.03B |
| EBITDA | 3.76B | 4.27B | 4.14B | 4.25B | 4.87B | 4.43B |
| Net Income | 1.75B | 2.07B | 2.61B | 2.33B | 1.57B | 2.83B |
Balance Sheet | ||||||
| Total Assets | 28.23B | 28.71B | 27.83B | 29.49B | 30.96B | 29.09B |
| Cash, Cash Equivalents and Short-Term Investments | 497.02M | 1.44B | 1.08B | 1.34B | 1.85B | 1.29B |
| Total Debt | 11.23B | 10.00B | 9.08B | 9.73B | 10.26B | 10.07B |
| Total Liabilities | 23.63B | 23.28B | 21.80B | 22.85B | 23.48B | 23.15B |
| Stockholders Equity | 4.03B | 4.82B | 5.44B | 6.02B | 6.86B | 5.35B |
Cash Flow | ||||||
| Free Cash Flow | 2.81B | 2.86B | 3.27B | 2.95B | 2.58B | 1.57B |
| Operating Cash Flow | 3.11B | 3.24B | 3.31B | 3.13B | 2.83B | 1.77B |
| Investing Cash Flow | -357.43M | -415.00M | -348.00M | -437.00M | -163.00M | 695.00M |
| Financing Cash Flow | -2.90B | -2.52B | -3.16B | -2.63B | -2.15B | -2.79B |
Imperial Brands Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IMBBY, the sentiment is Positive. The current price of 40.34 is above the 20-day moving average (MA) of 36.71, above the 50-day MA of 34.78, and above the 200-day MA of 37.33, indicating a bullish trend. The MACD of 1.32 indicates Negative momentum. The RSI at 77.54 is Negative, neither overbought nor oversold. The STOCH value of 92.97 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IMBBY.
Imperial Brands Risk Analysis
Imperial Brands disclosed 12 risk factors in its most recent earnings report. Imperial Brands reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksImperial Brands Peers Comparison
Overall Rating
RLX69Neutral
BTI68Neutral
PM68Neutral
IMBBY66Neutral
MO65Neutral
TPB65Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | $1.97B | 13.37 | 6.20% | 6.83% | 59.23% | 39.66% | |
| 68Neutral | $132.14B | 15.73 | 13.38% | 5.40% | 4.47% | 117.22% | |
| 68Neutral | $325.43B | 30.48 | -119.68% | 2.88% | 7.91% | 24.06% | |
| 66Neutral | $29.43B | 13.79 | 39.24% | 5.49% | 10.00% | -25.42% | |
| 65Neutral | $129.80B | 16.12 | -279.72% | 5.50% | 2.41% | -7.63% | |
| 65Neutral | $1.35B | 28.28 | 11.93% | 0.47% | 20.10% | -3.19% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IMBBY | Imperial Brands PLC (ADR) | 39.36 | 1.31 | 3.45% | |
| MO | Altria | 78.03 | 24.95 | 47.00% | |
| BTI | British American Tobacco | 61.52 | 12.03 | 24.30% | |
| PM | Philip Morris International | 208.79 | 69.13 | 49.50% | |
| TPB | Turning Point Brands Inc | 67.31 | -25.97 | -27.84% | |
| RLX | Rlx Technology, Inc. | 1.61 | -0.69 | -29.97% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 19, 2026